Phase II Clinical Trial: Multi-dosing the BCG Vaccine for Fibromyalgia

Exclusion Criteria

• •History of HIV or hepatitis
• •History of tuberculosis, mycobacterium exposure, TB risk factors, positive interferon-gamma release assay (IGRA, also known as T-SPOT.TB test) or BCG vaccination
• •Current treatment with glucocorticoids or disease likely to require steroid therapy
• •Conditions or treatments associated with risk of infections such as patients with a previous history of severe burns, or treatment with immunosuppressive medications of any type
• •Daily use of aspirin \> 160 mg, or chronic, daily NSAIDs
• •Current treatment with antibiotics
• •History of keloid formation
• •Severe pain due to other conditions
• •Current treatment with any Type II diabetes medication (such as metformin, farxiga, etc.)
• •Pregnant or not using acceptable birth control
• •Living with someone who is immunosuppressed and/or at high risk for infectious diseases